Skip to main content
Paul Corn, MD, Oncology, Houston, TX

Paul G. Corn MD


Associate Professor, Department of Genitourinary Medical Oncology, Division

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Are you Dr. Corn?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Paul Corn, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is an Associate Professor at Division.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1993 - 1996
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1993
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1993

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2005 - 2026
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 2000 - 2004
  • MD State Medical License
    MD State Medical License 1996 - 2000
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Cancer Death Rates down but Racial Disparities Persist Among Black Men and Women
    Cancer Death Rates down but Racial Disparities Persist Among Black Men and WomenJanuary 12th, 2023
  • Expert Sees Checkpoint and PARP Inhibitors Building on mCRPC Success
    Expert Sees Checkpoint and PARP Inhibitors Building on mCRPC SuccessMarch 14th, 2017
  • Study Identifies Possible New Combination Chemotherapy for Patients with Advanced Prostate Cancer
    Study Identifies Possible New Combination Chemotherapy for Patients with Advanced Prostate CancerMay 30th, 2015

Grant Support

  • Comprehensive Assessment of Cancer Theranostics ResponseAIQ SOLUTIONS, INC.2023–2025